GSK Pharma's Bengaluru facility to be operational by 2017
GlaxoSmithKline Pharmaceuticals (GSK India) has said its greenfield manufacturing facility at Bengaluru, having an installed capacity of over 9 billion tablets and capsules per year, will be operational by 2017.
Aug 02, 2015, 15:18 PM IST